Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Trial Radar • ClinicalTrials.gov • Registry-linked

Trial Radar

1963 clinical trials with phase, status, specialty and registry links, summarised for rapid clinical review.

1963 recruiting AI clinical summaries
Explore Trial Collections Follow research updates
All Phases Phase I Phase II Phase III Phase IV
Therapeutic Area: All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Haematology Infectious Disease Men's Health Mental Health / Psychiatry Nephrology Neurology Oncology Rare Diseases
🔬
Trial Radar

Clinical Trial Intelligence

● Recruiting Respiratory / COPD / Asthma
Investigating the Impact of Early Time-Restricted Eating on Health Outcomes and Quality of Life in Adults With Mild Controlled Asthma Compared to Healthy Adults
What is being tested: Early time-restricted eating (eTRE), where all daily meals are consumed within a specific time window, and its effects on health…
13 Aug 2026 NCT07345572
● Recruiting Phase III Oncology
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
What is being tested: Adjuvant (post-surgical) therapy combining Intismeran (V940), a personalized neoantigen vaccine, with or without pembrolizumab coformulated with berahyaluronidase alfa (MK-3475A), a…
13 Aug 2026 NCT07513376
● Recruiting Infectious Disease
Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access
What is being tested: Safety and performance of GORE® ACUSEAL Vascular Graft, a synthetic vascular access device for haemodialysis in patients with end-stage renal…
13 Aug 2026 NCT05846581
● Recruiting Respiratory / COPD / Asthma
The Barts Charity Children’s Environmental Health Clinic
What is being tested: Personal environmental exposure monitoring combined with home environmental assessments in children with chronic respiratory conditions to identify and characterise environmental…
13 Aug 2026 NCT06447974
● Recruiting Cardiology / Cardiovascular
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
What is being tested: The VDyne Transcatheter Tricuspid Valve Replacement System, a minimally invasive device designed to replace the tricuspid valve in patients with…
13 Aug 2026 NCT05797519
● Recruiting Cardiology / Cardiovascular
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
What is being tested: Long-term safety and performance of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System in treating thoracic aortic…
13 Aug 2026 NCT06658730
active not recruiting Phase III Neurology
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)
Trial testing a new drug (LP352) against placebo for seizures in children and adults with severe developmental epilepsy over two years.
12 Aug 2026 NCT06719141
active not recruiting Cardiology / Cardiovascular
Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction.
A device inserted into the coronary sinus improves blood flow and symptoms in patients with chest pain despite normal coronary arteries.
12 Aug 2026 NCT05492110
active not recruiting Phase II Oncology
ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)
SURPASS-3 Trial Summary A phase 2 trial testing a new cell therapy alone or combined with immunotherapy in women with recurrent ovarian cancer.
12 Aug 2026 NCT05601752
active not recruiting Phase II Neurology
A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer’s Disease (AD)
Testing RO7269162 drug versus placebo in people with early-stage Alzheimer's disease brain changes over 90 weeks.
12 Aug 2026 NCT06402838
● Recruiting Phase II
A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease
Trial testing a new sickle cell drug in children to check how the body processes it and whether it's safe over 96 weeks.
12 Aug 2026 NCT06198712
● Recruiting Phase II / Phase III
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
Trial testing efgartigimod IV dosing in teenagers with chronic immune thrombocytopenia to find correct treatment dose.
12 Aug 2026 NCT07194850
● Recruiting
An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
Long-term study showing octreotide depot injections safely and effectively control acromegaly symptoms in routine clinical practice over two years.
12 Aug 2026 NCT07583563
● Recruiting Phase II Infectious Disease
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
AZD5148 antibody reduces repeat Clostridioides difficile infections in adults compared to placebo.
12 Aug 2026 NCT07285213
● Recruiting Phase II
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
A drug (sonefpeglutide) tested in patients with severe bowel disease to see if injections are safe and effective.
12 Aug 2026 NCT04775706
active not recruiting Phase III
An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps
Long-term safety and effectiveness study of itepekimab injections for adults with chronic nasal polyps inadequately controlled by standard treatment.
12 Aug 2026 NCT07424144
● Recruiting Oncology
New bioMarkers tO straTIfy cOlorectal caNcer Referrals
What is being tested: A blood test measuring circulating progastrin (hPG80) and transposable elements (TEs) to predict colorectal cancer or polyps in adults referred…
12 Aug 2026 NCT07035691
● Recruiting Neurology
Artificial Intelligence-Assisted Magnetic Resonance Imaging for Quality, Efficiency and Equity in the National Health Service (NHS) Care of Multiple Sclerosis
What is being tested: AI-assisted MRI technology designed to improve the speed, accuracy, and consistency of brain and spinal cord imaging interpretation for MS…
12 Aug 2026 NCT07111637
● Recruiting Phase I Rheumatology
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
What is being tested: AZD0120, a dual CAR T cell therapy targeting CD19 and BCMA, is being investigated as a potential treatment for adults…
12 Aug 2026 NCT06897930
● Recruiting Cardiology / Cardiovascular
Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular Tachycardia
What is being tested: Non-invasive mapping technology to identify and eliminate ventricular tachycardia in patients with structural heart disease from previous myocardial infarction, potentially…
12 Aug 2026 NCT07759427
● Recruiting Oncology
Cerebellar Mutism Syndrome Study
What is being tested: The study investigates the mechanisms underlying Cerebellar Mutism Syndrome (CMS), a postoperative complication affecting up to 25% of children undergoing…
12 Aug 2026 NCT02300766
● Recruiting Phase I Oncology
Anti-GD2 ADC M3554 in Advanced Solid Tumors
What is being tested: M3554 is an anti-GD2 antibody-drug conjugate (ADC) being evaluated for dose optimisation and safety assessment in patients with advanced soft…
12 Aug 2026 NCT06641908
● Recruiting Phase I Oncology
TT-702 in Patients With Advanced Solid Tumours.
What is being tested: TT-702 is a novel drug candidate undergoing evaluation for safety, tolerability, and optimal dosing in patients with advanced solid tumours,…
12 Aug 2026 NCT05272709
active not recruiting Phase III Gastroenterology
Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)
Maralixibat safely reduced severe itching in patients with cholestatic liver disease who hadn't responded to other treatments.
11 Aug 2026 NCT06553768
● Recruiting
A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSmile® Aligners.
SureSmile clear aligners tested across three gum-line designs to check safety and accuracy of tooth movements.
11 Aug 2026 NCT07290790
● Recruiting Phase III
A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping
New drug tested for Duchenne muscular dystrophy in patients whose genetic mutations can be treated by skipping exon 44.
11 Aug 2026 NCT07587242
● Recruiting
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
A trial testing whether a microcurrent stimulation device applied through the eyelid safely improves vision in intermediate-to-advanced dry age-related macular degeneration.
11 Aug 2026 NCT06662162
active not recruiting Phase I Oncology
Immunotherapy Using CAR T-cells to Target CD19 for Relapsed/Refractory CD19+ Primary CNS Lymphoma
CD19 CAR T-cell therapy tested for safety and effectiveness in patients with relapsed/refractory brain lymphoma.
11 Aug 2026 NCT04443829
● Recruiting
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Real-world study examining how ATTR amyloidosis patients present, are treated, and their outcomes including quality of life and disability.
11 Aug 2026 NCT06355934
active not recruiting Oncology
A Prospective Natural History Study in Uveal Melanoma
Multicenter registry tracking uveal melanoma patients over time to understand disease progression and support new treatment development.
11 Aug 2026 NCT04588662
● Recruiting Phase I / Phase II
Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy
Gene therapy SRP-1003 tested for safety and effectiveness in patients with type 1 myotonic dystrophy.
11 Aug 2026 NCT06138743
active not recruiting Phase II
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
ALXN2030 drug tested against placebo to see if it improves kidney damage from antibody rejection in transplant patients.
11 Aug 2026 NCT06744647
● Recruiting Phase I Oncology
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
Investigational Agent: GDC-1261 is being tested for the first time in prostate cancer patients to assess its safety profile, how the body processes it…
11 Aug 2026 NCT07567846
● Recruiting Neurology
Lived Experience Narratives in Dementia
What is being tested: The LEND research programme is investigating how narrative-based interventions can benefit people living with dementia across multiple work packages, with…
11 Aug 2026 NCT07757178
● Recruiting Neurology
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
What is being tested: The study evaluates the safety of diroximel fumarate (DRF/Vumerity) exposure during pregnancy by estimating the risk of major congenital malformations…
11 Aug 2026 NCT05658497
● Recruiting Gastroenterology
International Wilson’s Disease Patient Registry (iWilson Registry)
What is being tested: The iWilson Registry is a longitudinal, observational study collecting standardised clinical data from Wilson's disease patients attending routine clinic visits…
11 Aug 2026 NCT05239858
● Recruiting Phase I Respiratory / COPD / Asthma
A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
TSRA-196 is being tested as a potential therapeutic intervention in adults with PiZZ alpha-1 antitrypsin deficiency (AATD), a serious genetic disorder causing progressive lung…
11 Aug 2026 NCT07227207
● Recruiting Rheumatology
PIBD-SETQuality: the Inception Cohort and Safety Registry
What is being tested: Effectiveness and safety of current treatment strategies for pediatric-onset inflammatory bowel disease (IBD) in routine clinical practice, with correlation to…
11 Aug 2026 NCT03571373
● Recruiting Phase II Cardiology / Cardiovascular
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
What is being tested: PRX-102, a novel therapeutic agent, is being evaluated for safety and efficacy in the paediatric population (children and adolescents) with…
11 Aug 2026 NCT06328608
● Recruiting Phase I Oncology
A Study of MGC026 in Participants With Advanced Solid Tumors
What is being tested: MGC026, a novel therapeutic agent, is being evaluated for safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity in patients with advanced…
11 Aug 2026 NCT06242470
● Recruiting Phase I Oncology
Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC
What is being tested: A combination of bexmarilimab (a CSF-1R inhibitor) with nivolumab (a PD-1 checkpoint inhibitor) in patients with advanced melanoma and non-small…
11 Aug 2026 NCT07718243
● Recruiting Phase I Oncology
Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies
What is being tested: KCAT19 evaluates allogeneic T cells engineered with dual receptors (TCR-KDEL and CAR-targeting CD19) as a novel immunotherapy for advanced, treatment-resistant…
11 Aug 2026 NCT05391490
● Recruiting Phase III Oncology
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Trial testing whether mRNA vaccine plus immunotherapy reduces lung cancer recurrence after surgery in high-risk patients.
10 Aug 2026 NCT07513376
● Recruiting Phase II
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Trial testing ARGX-119 injections in children aged 5-17 with spinal muscular atrophy alongside standard treatment.
10 Aug 2026 NCT07287982
● Recruiting Phase III Gastroenterology
A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn’s Disease
Trial testing a new drug (Afimkibart) for treating moderate-to-severe Crohn's disease in children.
10 Aug 2026 NCT07298421
active not recruiting Phase III Diabetes / Metabolic
A Trial of Setmelanotide in Acquired Hypothalamic Obesity
Setmelanotide daily injections tested for weight loss and quality of life improvement in acquired hypothalamic obesity patients aged 4+ years.
10 Aug 2026 NCT05774756
active not recruiting Phase II Gastroenterology
A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)
Gene therapy trial testing safety and effectiveness of a new treatment for very young children with Duchenne muscular dystrophy over five years.
10 Aug 2026 NCT06128564
● Recruiting Cardiology / Cardiovascular
Improving Sleep and Learning in Rehabilitation After Stroke, Part 2
Digital cognitive behavioural therapy improves sleep in stroke survivors and may enhance motor learning recovery compared to standard care.
10 Aug 2026 NCT05511285
● Recruiting Phase III Rheumatology
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Baricitinib safety and effectiveness for children aged 1-17 with juvenile idiopathic arthritis.
07 Aug 2026 NCT03773965
● Recruiting
3D Animation and Models to Aid Management of Fetal CDH
3D models of unborn babies with lung defects help parents understand the condition and surgeons plan birth operations.
07 Aug 2026 NCT03750266